Advertisement
Screener

GUARDANT HEALTH, INC. (GH) Overview

GUARDANT HEALTH, INC. (GH) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.90; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.85; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.74; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.80; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$74.67$90.22$109.00$131.70$159.12$192.262025-11-062026-11-06$15.27$25.34$42.05$69.79$115.84$192.262021-11-082026-11-06$15.27$25.34$42.05$69.79$115.84$192.262018-10-042026-11-06$15.27$25.34$42.05$69.79$115.84$192.262018-10-042026-11-06$15.27$25.34$42.05$69.79$115.84$192.262018-10-042026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$151.30
Previous close
$177.73
Change
-$26.43
Change (%)
-14.87%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

GH
+74.01%
S&P 500
(m)

1 year

GH
+186.71%
S&P 500
(m)

3 years

GH
+499.63%
S&P 500
(m)

5 years

GH
+46.76%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.90

-0.98-0.88-0.77-0.67-0.5631 Mar 2025: estimate (m); actual -0.7731 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.8030 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.7430 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.8531 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.9030 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.90(m)(m)
1 Jan 202631 Mar 2026(m)-0.85(m)(m)
1 Jul 202530 Sept 2025(m)-0.74(m)(m)
1 Apr 202530 Jun 2025(m)-0.80(m)(m)
1 Jan 202531 Mar 2025(m)-0.77(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -3.32

-6.49-5.65-4.81-3.98-3.1431 Dec 2021: estimate (m); actual -4.0031 Dec 2021(m)31 Dec 2022: estimate (m); actual -6.4131 Dec 2022(m)31 Dec 2023: estimate (m); actual -4.2831 Dec 2023(m)31 Dec 2024: estimate (m); actual -3.5631 Dec 2024(m)31 Dec 2025: estimate (m); actual -3.3231 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-3.32(m)(m)
1 Jan 202431 Dec 2024(m)-3.56(m)(m)
1 Jan 202331 Dec 2023(m)-4.28(m)(m)
1 Jan 202231 Dec 2022(m)-6.41(m)(m)
1 Jan 202131 Dec 2021(m)-4.00(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 334.98M ■ Earnings -120.14M — Profit margin -35.87%

-184.14M-46.7%7.44M-42.4%199.02M-38.2%390.60M-34.0%30 Sept 2025: revenue 265.20M; earnings -92.72M; profit margin -34.96%30 Sept 202531 Dec 2025: revenue 281.27M*; earnings -128.52M*; profit margin -45.69%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 301.67M; earnings -112.08M; profit margin -37.15%31 Mar 202630 Jun 2026: revenue 334.98M; earnings -120.14M; profit margin -35.87%30 Jun 2026

31 Dec 2025 ■ Revenue 982.02M ■ Earnings -416.30M — Profit margin -42.39%

-850.99M-146.6%-174.52M-111.5%501.95M-76.5%1178.42M-41.4%31 Dec 2022: revenue 449.54M; earnings -654.60M; profit margin -145.62%31 Dec 202231 Dec 2023: revenue 563.95M; earnings -479.40M; profit margin -85.01%31 Dec 202331 Dec 2024: revenue 739.02M; earnings -436.40M; profit margin -59.05%31 Dec 202431 Dec 2025: revenue 982.02M; earnings -416.30M; profit margin -42.39%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$151.30(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$151.30High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning GH

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-453.46M
Profit margin
-38.33%
Return on assets · 12 month
-27.95%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
1.85M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
0.32%*
Total return · month
10.05%*
Total return · quarter
15.60%*
Total return · half year
110.06%*
Total return · year to date
74.01%*
Total return · 1 year
186.71%*
Total return · 3 years
499.63%*
Total return · 5 years
46.76%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$1.18B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

GUARDANT HEALTH, INC. Overview

View more →

(m)

(m)

SEC CIK
1576280
Industry (SIC)
8071 Services-Medical Laboratories
Country of operation
United States
Business address
3100 HANOVER STREET, PALO ALTO, California, 94304, United States
Fiscal year end
1231
Phone
855-698-8887

Similar stocks

Stock NameCountryMarket CapPE Ratio
LABCORP HOLDINGS INC. (LH)United States$25.060B22.60
QUEST DIAGNOSTICS INC (DGX)United States$26.096B22.09
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
RadNet, Inc. (RDNT)United States$5.611B-229.65
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30